<?xml version="1.0" encoding="UTF-8"?>
<p>A type I membrane zinc metalloprotease named angiotensin‐converting enzyme 2 (ACE2) is mainly expressed in arterial cells and lung alveolar epithelial cells. ACE2 hydrolyses the angiotensin I to produce angiotensin (1–9) (Donoghue et al., 
 <xref rid="tbed13734-bib-0024" ref-type="ref">2000</xref>). The enzyme is known for its implication as the virus receptor of SARS‐CoV (Kuba et al., 
 <xref rid="tbed13734-bib-0037" ref-type="ref">2005</xref>) which was proved as the cellular receptor of SARS‐CoV‐2 by Zhou et al (Zhou et al., 
 <xref rid="tbed13734-bib-0104" ref-type="ref">2020</xref>). Blocking the entrance of SARS‐CoV‐2 through the intervention of ACE2 seems to be a possible target for anti‐viral drug discovery.
</p>
